Analytical Data
-
Gene name
TCEAL8
- Application
-
Alternative Names
TCEAL8；Transcription elongation factor A Protein-like 8
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IYN2
-
Expression Region
1-117aa
-
AA Sequence
MQKSCEENEG KPQNMPKAEE DRPLEDVPQE AEGNPQPSEE GVSQEAEGNP RGGPNQPGQG FKEDTPVRHL DPEEMIRGVD ELERLREEIR RVRNKFVMMH WKQRHSRSRP YPVCFRPLEH HHHHH
-
Molecular Weight
15 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TCEAL8, or T-complex 1-associated protein 8, is a member of the TCEAL family of proteins, which are implicated in various cellular processes, including transcription regulation and stress response. Research on TCEAL8 has gained attention due to its potential role in modulating gene expression and influencing cell proliferation and differentiation. It has been suggested that TCEAL8 may play a critical role in the development of specific diseases, including cancer, where altered expression of this protein could contribute to tumorigenesis. Studies have shown that TCEAL8 might interact with other proteins involved in regulating transcription, thereby affecting the expression of oncogenes and tumor suppressor genes. Understanding the molecular mechanisms underlying TCEAL8 function can provide insights into its role in normal cellular physiology as well as in pathological conditions. Recent advancements in recombinant protein technology have facilitated the study of TCEAL8, allowing researchers to investigate its structure, function, and interactions within a cellular context. This research could pave the way for novel therapeutic strategies targeting TCEAL8 in cancer and other diseases, making it a significant focus of current biomedical research.
